A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Hoffmann-La Roche
Related studies linked through entity extraction aliases.
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC).
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.
- Status
- COMPLETED
- Phase
- N/A
Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Mass Balance and Absolute Bioavailability Study of RO7049389 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of AT-527 in Healthy Subjects (R07496998)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade
- Status
- TERMINATED
- Phase
- PHASE2